# Assessing the inhibition efficacy of clinical drugs against the main proteases of SARS‐CoV‐2 variants and other coronaviruses

**Authors:** Wenlong Zhao, Cecylia S. Lupala, Shifeng Hou, Shuxin Yang, Ziqi Yan, Shujie Liao, Xuefei Li, Nan Li

PMC · DOI: 10.1002/qub2.60 · Quantitative Biology · 2024-07-06

## Full-text entities

- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12806454/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12806454/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12806454/full.md

---
Source: https://tomesphere.com/paper/PMC12806454